B

Bergenbio ASA
OSE:BGBIO

Watchlist Manager
Bergenbio ASA
OSE:BGBIO
Watchlist
Price: 11.8 NOK -5.9% Market Closed
Market Cap: 479.2m NOK
Have any thoughts about
Bergenbio ASA?
Write Note

EV/OCF
Enterprise Value to OCF

-2.1
Current
-421.6
Median
5.7
Industry
Higher than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-2.1
=
Enterprise Value
296.2m NOK
/
Operating Cash Flow
-139m NOK
All Countries
Close
Market Cap EV/OCF
NO
Bergenbio ASA
OSE:BGBIO
461.2m NOK -2.1
FR
Pharnext SCA
OTC:PNEXF
6T USD -237 522.5
US
Abbvie Inc
NYSE:ABBV
325.5B USD 22.8
US
Amgen Inc
NASDAQ:AMGN
150.4B USD 27.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.9B USD -134.4
US
Gilead Sciences Inc
NASDAQ:GILD
115.7B USD 10.9
US
Epizyme Inc
F:EPE
94.1B EUR -474
AU
CSL Ltd
ASX:CSL
135.7B AUD 35.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
83.7B USD 18
US
Seagen Inc
F:SGT
39.3B EUR -74.2
NL
argenx SE
XBRU:ARGX
34.6B EUR -127.9
 
NO
B
Bergenbio ASA
OSE:BGBIO
Average EV/OCF: 22.9
Negative Multiple: -2.1
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -237 522.5
US
Abbvie Inc
NYSE:ABBV
22.8
US
Amgen Inc
NASDAQ:AMGN
27.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -134.4
US
Gilead Sciences Inc
NASDAQ:GILD
10.9
US
E
Epizyme Inc
F:EPE
Negative Multiple: -474
AU
CSL Ltd
ASX:CSL
35.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
US
S
Seagen Inc
F:SGT
Negative Multiple: -74.2
NL
argenx SE
XBRU:ARGX
Negative Multiple: -127.9

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A

See Also

Discover More